10.50
-6.42%
Close of 9 Nov 2026, in EUR
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in EUR, from our data supplier.
Revenue
€1.11bn
FY2016FY2025
Net income
€46.2m
FY2016FY2025
Free cash flow
€134.3m
FY2016FY2025
Shareholders' equity
€1.49bn
FY2016FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | €1.11bn | €985.7m | €894.5m | €863.2m | €827.2m | €1.61bn | €855.3m | €756.9m | €639.4m | €764.4m |
| Research and development | €138.1m | €79.0m | €66.9m | €64.3m | €42.0m | €44.1m | €47.7m | €87.6m | €87.9m | €98.3m |
| Operating income | €67.7m | €36.1m | −€5.3m | €46.9m | €105.4m | €92.3m | €149.9m | €87.0m | −€299.9m | €130.5m |
| Net income | €46.2m | €10.1m | −€38.5m | €4.3m | −€40.9m | €74.3m | €105.9m | €77.7m | −€304.0m | €75.5m |
| Diluted earnings per share | 0.22 | 0.05 | -0.18 | 0.02 | -0.23 | 0.42 | 0.61 | 0.44 | -1.76 | 0.44 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | €2.34bn | €2.40bn | €2.37bn | €2.15bn | €2.14bn | €2.29bn | €2.44bn | €2.39bn | €2.18bn | €2.82bn |
| Cash and short-term investments | €338.8m | €377.3m | €388.1m | €248.8m | €207.4m | €165.7m | €117.3m | €86.3m | €280.2m | €466.7m |
| Total liabilities | €829.7m | €908.3m | €911.6m | €829.0m | €855.7m | €988.1m | €1.16bn | €1.20bn | €1.04bn | €1.30bn |
| Debt | €308.4m | €408.8m | €403.2m | €403.9m | €392.3m | €491.3m | €495.8m | €525.9m | €250.0m | €317.2m |
| Shareholders' equity | €1.49bn | €1.49bn | €1.46bn | €1.32bn | €1.29bn | €1.30bn | €1.28bn | €1.19bn | €1.13bn | €1.52bn |
| Shares outstanding | 215m | 213m | 209m | 182m | 180m | 179m | 174m | 176m | 173m | 173m |
Cash flow
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | €169.2m | €160.8m | €93.5m | €155.1m | €233.9m | €164.8m | €276.1m | €143.2m | €6.1m | €105.1m |
| Capital spending | −€34.9m | −€161.4m | −€159.3m | −€116.5m | −€71.2m | −€76.5m | −€135.1m | −€598.5m | −€68.8m | −€76.6m |
| Free cash flow | €134.3m | −€664,000 | −€65.8m | €38.6m | €162.7m | €88.2m | €141.1m | −€455.3m | −€62.7m | €28.4m |
| Dividends paid | −€26.2m | −€3.3m | −€2.6m | −€12.4m | −€11.7m | −€2.1m | −€24.1m | −€22.7m | −€33.0m | −€33.0m |
Latest quarters
By quarter end
| Jun 2026 | Mar 2026 | Dec 2025 | Sept 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | €310.3m | €291.0m | €547.6m | €260.2m | €274.4m | €286.1m | €258.1m | €230.4m |
| Operating income | €39.9m | €28.6m | €33.2m | €24.2m | €9.0m | €36.0m | €8.3m | −€32.7m |
| Net income | €24.3m | €15.3m | €19.6m | €12.5m | €5.0m | €21.6m | €2.9m | −€8.2m |
| Diluted earnings per share | 0.11 | 0.07 | 0.09 | 0.06 | 0.02 | 0.10 | 0.01 | -0.04 |
| Cash from operations | €79.0m | €48.0m | €112.0m | €88.0m | €31.0m | €26.0m | €54.0m | €39.0m |
| Capital spending | −€15.0m | −€23.0m | −€23.0m | — | −€72.0m | −€14.0m | −€115.0m | −€36.0m |
| Free cash flow | €64.0m | €25.0m | €89.0m | — | −€41.0m | €12.0m | −€61.0m | €3.0m |
| Total assets | €2.37bn | €2.33bn | €2.34bn | €2.36bn | €2.31bn | €2.40bn | €2.40bn | €2.31bn |
| Cash and short-term investments | €355.4m | €311.2m | €338.8m | €376.6m | €323.2m | €374.4m | €377.3m | €343.1m |
| Debt | €325.4m | €285.4m | €308.4m | €337.1m | €367.5m | €341.5m | €371.3m | €346.7m |
| Shareholders' equity | €1.53bn | €1.51bn | €1.49bn | €1.48bn | €1.46bn | €1.50bn | €1.49bn | €1.47bn |
Financial ratios
Data as of 25 Oct 2026
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | |
|---|---|---|---|---|---|---|
| Operating margin | 6.1% | 3.5% | -1.1% | 4.2% | 1.5% | 5.6% |
| Net margin | 4.2% | 1.0% | -4.3% | 0.5% | -4.9% | 4.6% |
| Return on equity | 3.1% | 0.7% | -2.6% | 0.3% | -3.2% | 5.7% |
| Return on assets | 2.0% | 0.4% | -1.6% | 0.2% | -1.9% | 3.2% |
| Free cash flow yield | 9.2% | 14.6% | 11.7% | 14.4% | 16.4% | 13.0% |
| Revenue growth | 12.4% | 10.2% | 3.6% | 4.4% | -48.8% | 88.8% |
| Earnings growth | 355.3% | -126.4% | -998.7% | -110.5% | -155.0% | -29.9% |
| Current ratio | 2.04x | 2.10x | 2.05x | 2.01x | 1.78x | 1.03x |
| Debt to equity | 0.21x | 0.25x | 0.25x | 0.28x | 0.30x | 0.37x |
| Equity ratio | 63.6% | 62.1% | 61.6% | 61.4% | 60.0% | 56.9% |
| Interest coverage | 3.79x | 2.11x | -0.65x | 4.89x | 0.96x | 8.19x |
| R&D as a share of sales | 12.5% | 8.0% | 7.5% | 7.4% | 5.1% | 2.7% |
| Buybacks as a share of market value | -0.6% | -1.9% | -15.4% | -1.0% | -0.5% | -3.1% |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | 8.7% | -7.3% | 4.9% |
| Operating income | 13.1% | -6.0% | -8.7% |
| Net income | 121.0% | -9.1% | -10.0% |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Operating margin | 5.0% | 3.8% | 5.5% | 5.8% |
| Net margin | 2.7% | 0.6% | 0.9% | 1.4% |
Valuation history
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings | 59.7 | 173.2 | -45.9 | 383.3 | -49.7 | 26.3 | 24.0 | 30.3 | -4.8 | 33.8 |
| Price to sales | 2.5 | 1.8 | 2.0 | 1.9 | 2.5 | 1.2 | 3.0 | 3.1 | 2.3 | 3.3 |
Dividends and splits
Per share, in the currency the company pays
Paid for 11 years. Last went ex-dividend on 14 May 2026.
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | |
|---|---|---|---|---|---|---|---|---|
| Paid in the year | 0.187 | 0.184 | 0.184 | 0.184 | 0.182 | 0.183 | 0.194 | 0.195 |
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.